Castle Biosciences Inc (CSTL)

Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.52% 66.12	61.49	50.14	42.04	38.34
Cost Of Revenue	9.75% 12.42	11.32	11.06	10.18	9.52
Gross Profit	7.02% 53.70	50.17	39.08	31.86	28.82
Operating Expenses	0.77% 59.35	59.81	60.24	63.38	51.65
Interest Income/Expense	0.00% 0.002	0.002	0.003	0.004	0.004
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	0.91% 71.78	71.13	71.30	73.56	61.17
Operating Income/Loss	41.31% -5.658	-9.64	-21.16	-31.52	-22.83
Income/Loss From Continuing Operations Before Tax	7.52% 66.12	61.49	-18.78	-29.20	38.34
Income Tax Expense/Benefit, Deferred	-0.236	-	-	0.013	-0.038
Income Tax Expense/Benefit	21.87% 0.039	0.032	0.016	0.014	0.057
Income/Loss From Continuing Operations After Tax	62.64% -2.58	-6.905	-18.78	-29.20	-20.62
Net Income/Loss	62.64% -2.58	-6.905	-18.78	-29.20	-20.62
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.71% 0.077	26.83	26.73	26.61	0.116
Diluted Average Shares	99.71% 0.077	26.83	26.73	26.61	0.116
Basic Earnings Per Share	65.38% -0.09	-0.26	-0.70	-1.10	-0.79
Diluted Earnings Per Share	65.38% -0.09	-0.26	-0.70	-1.10	-0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-